Skip to main content

Week In Review: Pfizer Picks Sinopharm To Market 12 Of Its Novel Drugs

Pfizer (PFE) announced a major partnership with Shanghai’s Sinopharm to market up to 12 innovative drugs in China over the next three years.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.